These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 25539192)
1. MMPs-2 and -14 Are Elevated in Eosinophilic Esophagitis and Reduced Following Topical Corticosteroid Therapy. Beppu L; Yang T; Luk M; Newbury RO; Palmquist J; Dohil R; Kurten RC; Broide DH; Aceves SS J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):194-9. PubMed ID: 25539192 [TBL] [Abstract][Full Text] [Related]
2. TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis. Rawson R; Yang T; Newbury RO; Aquino M; Doshi A; Bell B; Broide DH; Dohil R; Kurten R; Aceves SS J Allergy Clin Immunol; 2016 Sep; 138(3):791-800.e4. PubMed ID: 27212082 [TBL] [Abstract][Full Text] [Related]
3. Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids. Rajan J; Newbury RO; Anilkumar A; Dohil R; Broide DH; Aceves SS J Allergy Clin Immunol; 2016 Jan; 137(1):147-156.e8. PubMed ID: 26233926 [TBL] [Abstract][Full Text] [Related]
4. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. Kagalwalla AF; Akhtar N; Woodruff SA; Rea BA; Masterson JC; Mukkada V; Parashette KR; Du J; Fillon S; Protheroe CA; Lee JJ; Amsden K; Melin-Aldana H; Capocelli KE; Furuta GT; Ackerman SJ J Allergy Clin Immunol; 2012 May; 129(5):1387-1396.e7. PubMed ID: 22465212 [TBL] [Abstract][Full Text] [Related]
5. Antifibrotic Effects of the Thiazolidinediones in Eosinophilic Esophagitis Pathologic Remodeling: A Preclinical Evaluation. Nhu QM; Hsieh L; Dohil L; Dohil R; Newbury RO; Kurten R; Moawad FJ; Aceves SS Clin Transl Gastroenterol; 2020 Apr; 11(4):e00164. PubMed ID: 32352681 [TBL] [Abstract][Full Text] [Related]
6. Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitis. Simon D; Page B; Vogel M; Bussmann C; Blanchard C; Straumann A; Simon HU Allergy; 2018 Jan; 73(1):239-247. PubMed ID: 28712126 [TBL] [Abstract][Full Text] [Related]
7. TGF-β1 alters esophageal epithelial barrier function by attenuation of claudin-7 in eosinophilic esophagitis. Nguyen N; Fernando SD; Biette KA; Hammer JA; Capocelli KE; Kitzenberg DA; Glover LE; Colgan SP; Furuta GT; Masterson JC Mucosal Immunol; 2018 Mar; 11(2):415-426. PubMed ID: 28832026 [TBL] [Abstract][Full Text] [Related]
9. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. Lucendo AJ; Arias A; De Rezende LC; Yagüe-Compadre JL; Mota-Huertas T; González-Castillo S; Cuesta RA; Tenias JM; Bellón T J Allergy Clin Immunol; 2011 Nov; 128(5):1037-46. PubMed ID: 21880354 [TBL] [Abstract][Full Text] [Related]
10. Smad3-deficient mice have reduced esophageal fibrosis and angiogenesis in a model of egg-induced eosinophilic esophagitis. Cho JY; Doshi A; Rosenthal P; Beppu A; Miller M; Aceves S; Broide D J Pediatr Gastroenterol Nutr; 2014 Jul; 59(1):10-6. PubMed ID: 24590208 [TBL] [Abstract][Full Text] [Related]
11. Increased Production of LIGHT by T Cells in Eosinophilic Esophagitis Promotes Differentiation of Esophageal Fibroblasts Toward an Inflammatory Phenotype. Manresa MC; Chiang AWT; Kurten RC; Dohil R; Brickner H; Dohil L; Herro R; Akuthota P; Lewis NE; Croft M; Aceves SS Gastroenterology; 2020 Nov; 159(5):1778-1792.e13. PubMed ID: 32712105 [TBL] [Abstract][Full Text] [Related]
15. Factors Associated With Adequate Lamina Propria Sampling and Presence of Lamina Propria Fibrosis in Children with Eosinophilic Esophagitis. Hiremath G; Choksi YA; Acra S; Correa H; Dellon ES Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1814-1823.e1. PubMed ID: 32707338 [TBL] [Abstract][Full Text] [Related]
16. Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis. Merves J; Chandramouleeswaran PM; Benitez AJ; Muir AB; Lee AJ; Lim DM; Dods K; Mehta I; Ruchelli ED; Nakagawa H; Spergel JM; Wang ML PLoS One; 2015; 10(2):e0114831. PubMed ID: 25723478 [TBL] [Abstract][Full Text] [Related]
17. Plasminogen Activator Inhibitor-1 as a Marker of Esophageal Functional Changes in Pediatric Eosinophilic Esophagitis. Williamson P; Proudfoot J; Gharibans A; Dohil L; Newbury R; Barsamian J; Hassan M; Rawson R; Katzka D; Kurten R; Dohil R; Mousa H; Aceves S Clin Gastroenterol Hepatol; 2022 Jan; 20(1):57-64.e3. PubMed ID: 33007513 [TBL] [Abstract][Full Text] [Related]
18. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis. Rieder F; Nonevski I; Ma J; Ouyang Z; West G; Protheroe C; DePetris G; Schirbel A; Lapinski J; Goldblum J; Bonfield T; Lopez R; Harnett K; Lee J; Hirano I; Falk G; Biancani P; Fiocchi C Gastroenterology; 2014 May; 146(5):1266-77.e1-9. PubMed ID: 24486052 [TBL] [Abstract][Full Text] [Related]